NASDAQ · BNKK

Bonk, Inc.

$1.11 -$0.01 (-0.89%) 1D After hours

Key Metrics

$8.96M
Market cap
P/E · TTM
$2.86M
Revenue · TTM
−$64.69M
Net income
EPS · TTM $-0.68
Dividend yield
Free cash flow
Beta · 1Y 1.24
EBITDA · TTM
Gross margin 168.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jan 29 high, the share price fell 74%.

    Peak close $4.31 on Jan 29; trough close $1.11 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -74%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 7
    The stock moved -14.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 7
  • Apr 6
    The stock moved +14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.96M
Enterprise value
Shares outstanding8.0M
52-wk range$0.13 – $8.25
Avg volume · 20D3.4M
Net cash
Book value / share$0.35
IndustryPerfumes, Cosmetics & Other Toilet Preparations
ExchangeNASDAQ
About Bonk, Inc.
IPO dateOct 30, 2020
Employees10

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S3.13
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 168.1%
Operating
Net -2,260.6%
FCF
ROE / ROIC -415.9% · —

Financial Health

Current ratio1.28
Quick ratio1.13
Debt / equity
Debt / EBITDA
Net cash
Working capital$1.45M

Cash Flow · TTM

Operating CF −$22.59M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings